 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Current Price	$9.05
Prev Close	$9.04
Open	$9.04
Dividend Yield	0.00%
50-Day Moving Average	$6.47
Beta	0.83
Avg. Volume	10.42M
PE Ratio	-15.71

52-Week High	$9.06
52-Week Low	$4.01
Market Capitalization	$1.19B
EPS	-$0.5759
Price to Book	-47.09
Revenue Per Employee	$591,945.31
Enterprise Value/EBITDA	-6.03

CTIC CTI BioPharma Corp

About

Feed

Fundamentals

News